Estuary Capital Management LP Makes New Investment in Astera Labs, Inc. $ALAB

Estuary Capital Management LP bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund bought 170,958 shares of the company’s stock, valued at approximately $18,737,000. Astera Labs makes up about 3.1% of Estuary Capital Management LP’s investment portfolio, making the stock its 19th biggest position.

A number of other large investors also recently modified their holdings of ALAB. Vanguard Group Inc. increased its holdings in Astera Labs by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after buying an additional 84,365 shares during the last quarter. State Street Corp increased its stake in Astera Labs by 32.5% in the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after purchasing an additional 760,358 shares during the last quarter. Geode Capital Management LLC raised its holdings in Astera Labs by 4.5% during the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock worth $403,598,000 after purchasing an additional 104,935 shares in the last quarter. Fred Alger Management LLC raised its holdings in Astera Labs by 25.5% during the fourth quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock worth $321,855,000 after purchasing an additional 393,250 shares in the last quarter. Finally, Morgan Stanley lifted its position in shares of Astera Labs by 33.0% during the 4th quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock worth $321,818,000 after buying an additional 480,009 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ALAB. Needham & Company LLC increased their target price on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Citigroup downgraded shares of Astera Labs from a “buy” rating to a “market perform” rating in a research note on Tuesday, May 26th. Evercore reaffirmed an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. Stifel Nicolaus lifted their target price on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research report on Wednesday, June 24th. Finally, Roth Capital reissued a “buy” rating and issued a $275.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $282.00.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $282.52 on Tuesday. The firm’s fifty day simple moving average is $360.28 and its 200-day simple moving average is $226.92. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The stock has a market capitalization of $48.43 billion, a price-to-earnings ratio of 190.89, a PEG ratio of 3.38 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter in the prior year, the business earned $0.33 EPS. Astera Labs’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Analysts anticipate that Astera Labs, Inc. will post 1.86 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In related news, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the transaction, the director owned 57,466 shares of the company’s stock, valued at $25,859,700. This trade represents a 5.75% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 1,676,845 shares of company stock valued at $444,928,806. Corporate insiders own 10.40% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.